Highlights
- •Practicing Obstetricians use both risk-based and universal screening for Hepatitis C virus.
- •Professional guidance from OB/GYN, public health and infectious diseases societies are important factors is an important factor influencing what strategy they choose.
- •Now that universal screening for Hepatitis C is recommended for all adults, consensus guidelines should be created to endorse universal screening during pregnancy as an important step towards Hepatitis C eradication.
Abstract
Purpose
Hepatitis C virus (HCV) cases have increased in the past decade, with many cases in
pregnant patients. However, recommendations for HCV screening during pregnancy vary
by professional organization.
Methods
Prenatal care providers were surveyed via e-mail about factors affecting choice of
HCV screening.
Findings
A total of 86 completed surveys were received. Providers using risk-based screening
valued guidance from obstetrics and gynecology societies and risk for vertical transmission.
Providers using universal screening valued availability of curative treatment in addition
to guidance from the Centers for Disease Control and Prevention/infectious diseases societies
and obstetrics and gynecology societies.
Implications
The results highlight the need for consensus guidelines on HCV screening as a part
of prenatal care.
Key words
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Clinical TherapeuticsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Hepatitis C in pregnancy in the era of direct-acting antiviral treatment: potential benefits of universal screening and antepartum therapy.Clin Obstet Gynecol. 2018; 61: 146-156
- Universal screening of pregnant women for hepatitis C: the time is now.Clin Infect Dis. 2018; 67: 1493-1497
- Vital signs: newly reported acute and chronic hepatitis C cases—United States, 2009-2018.MMWR Morb Mortal Wkly Rep. 2020; 69: 399-404
- Hepatitis C virus infection among reproductive-aged women and children in the United States, 2006 to 2014.Ann Intern Med. 2017; 166: 775-782
- HCV in pregnancy.2018 ([updated August 27, 2020]. Available from:)https://www.hcvguidelines.org/unique-populations/pregnancyDate accessed: May 17, 2020
- CDC recommendations for hepatitis C screening among adults—United States, 2020.MMWR Recomm Rep. 2020; 69: 1-17
- Screening for hepatitis C virus infection in adolescents and adults: US Preventive Services Task Force recommendation statement.JAMA. 2020; 323: 970-975
- Hepatitis C in pregnancy: screening, treatment, and management.Am J Obstet Gynecol. 2017; 217: B2-B12
- New antiviral agents for treatment of hepatitis C.Clin Obstet Gynecol. 2019; 62: 823-834
- Ledipasvir plus sofosbuvir in pregnant women with hepatitis C virus infection: a phase 1 pharmacokinetic study.Lancet Microbe. 2020; 1: e200-e208
- Short-term effects and long-term cost-effectiveness of universal hepatitis C testing in prenatal care.Obstet Gynecol. 2019; 133: 289-300
- Healthy People 2030—Overview and Objectives: Infectious Diseases.DHHS, Bethesda, Md2020
Article info
Publication history
Published online: February 05, 2021
Accepted:
January 14,
2021
Identification
Copyright
© 2021 Elsevier Inc.
